Image guided, adaptive, accelerated, high dose brachytherapy as model for advanced small volume radiotherapy

Radiotherapy and Oncology

Volumn 100, Issue 3, 2011, Pages 333-343

  Haie Meder, Christine ^a   Siebert, Frank André ^b   Pötter, Richard ^c  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Accelerated brachytherapy; Adaptive brachytherapy; Brachytherapy research; Image guided brachytherapy

Indexed keywords

BRACHYTHERAPY; BREAST CANCER; CANCER RADIOTHERAPY; GYNECOLOGIC CANCER; HUMAN; IMAGE GUIDED BRACHYTHERAPY; MEDICAL LITERATURE; MEDICAL RESEARCH; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE; REVIEW; TRANSLATIONAL RESEARCH;

EID: 80054071767     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2011.09.011     Document Type: Article

References (240)

1. R. Pötter Image-guided brachytherapy sets benchmarks in advanced radiotherapy Radiother Oncol 91 2009 141 146
2. J.J. Mazeron Brachytherapy: a new era Radiother Oncol 74 2005 223 225
3. F. Guedea, J. Venselaar, and P. Hoskin Patterns of care for brachytherapy in Europe: updated results Radiother Oncol 97 2010 514 520
4. P.M. Poortmans, M.J. Aarts, and J.J. Jobsen A population-based study on the utilisation rate of primary radiotherapy for prostate cancer in 4 regions in The Netherlands, 1997-2008 Radiother Oncol 99 2011 207 213
5. J. Venselaar, B.J. Slotman, F. Guedea, M. Ventura, B. Londres, and G. Francois Patterns of care study for brachytherapy: results of the questionnaire for the years 2002 and 2007 in The Netherlands J Contemp Brachyther 2 2010 145 152
6. F. Guedea, P. Hoskin, and J.J. Mazeron Brachytherapy in the United Kingdom and Spain: a subset analysis of a European pattern of care survey Clin Transl Oncol 11 2009 534 538
7. C. Haie-Meder, R. Pötter, and E. Van Limbergen Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV Radiother Oncol 74 2005 235 245 (Pubitemid 40349132)
8. R. Pötter, C. Haie-Meder, and E. Van Limbergen Recommendations from Gynaecological (GYN) GEC ESTRO Working Group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose-volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology Radiother Oncol 78 2006 67 77 (Pubitemid 43131038)
9. In: Battermann J, volume editor. Brachytherapy for localized prostate cancer. Radiother Oncol 2000;57:249-352.
10. D. Ash, A. Flynn, J. Battermann, T. de Reijke, P. Lavagnini, and L. Blank ESTRO/EAU/EORTC recommendations on permanent seed implantation for localized prostate cancer Radiother Oncol 57 2000 315 321
11. C. Salembier, P. Lavagnini, and P. Nickers Tumour and target volumes in permanent prostate brachytherapy: a supplement to the ESTRO/EAU/EORTC recommendations on prostate brachytherapy Radiother Oncol 83 2007 3 10 (Pubitemid 46527942)
12. P.J. Hoskin, and J. Venselaar Prostate brachytherapy in Europe: growth, practice and guidelines Radiother Oncol 83 2007 1 2 (Pubitemid 46527943)
13. D. Ash, B. Al-Qaisieh, D. Bottomley, B. Carey, and J. Joseph The impact of hormone therapy on post-implant dosimetry and outcome following Iodine-125 implant monotherapy for localised prostate cancer Radiother Oncol 75 2005 303 306 (Pubitemid 41007975)
14. M. De Brabandere, C. Kirisits, R. Peeters, K. Haustermans, and F. Van den Heuvel Accuracy of seed reconstruction in prostate postplanning studied with a CT- and MRI-compatible phantom Radiother Oncol 79 2006 190 197 (Pubitemid 43867817)
15. M. Bues, E.J. Holupka, P. Meskell, and I.D. Kaplan Effect of random seed placement error in permanent transperineal prostate seed implant Radiother Oncol 79 2006 70 74
16. V. Lagerburg, M.A. Moerland, J.J. Lagendijk, and J.J. Battermann Measurement of prostate rotation during insertion of needles for brachytherapy Radiother Oncol 77 2005 318 323 (Pubitemid 41785343)
17. V. Lagerburg, M.A. Moerland, M. van Vulpen, and J.J. Lagendijk A new robotic needle insertion method to minimise attendant prostate motion Radiother Oncol 80 2006 73 77 (Pubitemid 44205310)
18. K.M. Kälkner, G. Kubicek, J. Nilsson, M. Lundell, S. Levitt, and S. Nilsson Prostate volume determination: differential volume measurements comparing CT and TRUS Radiother Oncol 81 2006 179 183 (Pubitemid 44780787)
19. G.J. Meijer, H.A. van den Berg, C.W. Hurkmans, P.E. Stijns, and J.H. Weterings Dosimetric comparison of interactive planned and dynamic dose calculated prostate seed brachytherapy Radiother Oncol 80 2006 378 384 (Pubitemid 44419431)
20. M.J. Zelefsky, Y. Yamada, and G.N. Cohen Intraoperative real-time planned conformal prostate brachytherapy: post-implantation dosimetric outcome and clinical implications Radiother Oncol 84 2007 185 189 (Pubitemid 47284532)
21. J.P. Nobes, S.J. Khaksar, M.A. Hawkins, M.J. Cunningham, S.E. Langley, and R.W. Laing Novel prostate brachytherapy technique: improved dosimetric and clinical outcome Radiother Oncol 88 2008 121 126
22. M.R. Van den Bosch, I.M. Lips, V. Lagerburg, M. van Vulpen, J.J.W. Lagendijk, and M.A. Moerland Feasibility of adequate dose coverage in permanent prostate brachytherapy using divergent needle insertion methods Radiother Oncol 86 2008 120 125
23. M. Pinkawa, B. Asadpour, and B. Gagel Evaluation of source displacement and dose-volume changes after permanent prostate brachytherapy with stranded seeds Radiother Oncol 84 2007 190 196 (Pubitemid 47299142)
24. M. Pinkawa, B. Asadpour, and M.D. Piroth Rectal dosimetry following prostate brachytherapy with stranded seeds - comparison of transrectal ultrasound intra-operative planning (day 0) and computed tomography-postplanning (day 1 vs. day 30) with special focus on sources placed close to the rectal wall Radiother Oncol 91 2009 207 212
25. S.V. Sejpal, V. Sathiaseelan, and I.B. Helenowski Intra-operative pubic arch interference during prostate seed brachytherapy in patients with CT-based pubic arch interference of 1 cm Radiother Oncol 91 2009 249 254
26. A. Polo, C. Salembier, J. Venselaar, and P. Hoskin Review of intraoperative imaging and planning techniques in permanent seed prostate brachytherapy Radiother Oncol 94 2010 12 23
27. C. Anderson, G. Lowe, and P. Ostler I-125 seed planning: an alternative method of urethra definition Radiother Oncol 94 2010 24 29
28. F.-A. Siebert, M. De Brabandere, C. Kirisits, G. Kovács, and J. Venselaar Phantom investigations on CT seed imaging for interstitial brachytherapy Radiother Oncol 85 2007 316 323 (Pubitemid 350161002)
29. O. Tanaka, S. Hayashi, and K. Sakurai Importance of the CT/MRI fusion method as a learning tool for CT-based postimplant dosimetry in prostate brachytherapy Radiother Oncol 81 2006 303 308 (Pubitemid 44873137)
30. O. Tanaka, S. Hayashi, and M. Matsuo MRI-based preplanning in low-dose-rate prostate brachytherapy Radiother Oncol 88 2008 115 120 (Pubitemid 351888891)
31. M.P. Van Gellekom, M.A. Moerland, H.K. Wijrdeman, and J.J. Battermann Quality of permanent prostate implants using automated delivery with seedSelectron versus manual insertion of RAPID Strands Radiother Oncol 73 2004 49 56 (Pubitemid 39304124)
32. H. Ishiyama, M. Kitano, and T. Satoh Difference in rectal dosimetry between pre-plan and post-implant analysis in transperineal interstitial brachytherapy for prostate cancer Radiother Oncol 78 2006 194 198 (Pubitemid 43344180)
33. B. Al-Qaisieh, D.W. Smith, E. Brearley, S. St. Clair, and P. Bownes Comprehensive I-125 multi-seed comparison for prostate brachytherapy: dosimetry and visibility analysis Radiother Oncol 84 2007 140 147 (Pubitemid 47284529)
34. M.J. Steggerda, L.M.F. Moonen, H.G. van der Poel, and C.J. Schneider The influence of geometrical changes on the dose distribution after I-125 seed implantation of the prostate Radiother Oncol 83 2007 11 17 (Pubitemid 46546442)
35. C.W. Thomas, A. Kruk, C.E. McGahan, I. Spadinger, and W.J. Morris Prostate brachytherapy post-implant dosimetry: a comparison between higher and lower source density Radiother Oncol 83 2007 18 24 (Pubitemid 46546441)
36. J.P. Nobes, R. Laing, and S. Langley The value of Day 1 imaging following LDR prostate brachytherapy Radiother Oncol 86 2008 288 (Pubitemid 351215195)
37. M.A. Moerland, M.J. van Deursen, S.G. Elias, M. van Vulpen, I.M. Jurgenliemk-Schulz, and J.J. Battermann Decline of dose coverage between intraoperative planning and post implant dosimetry for I-125 permanent prostate brachytherapy: comparison between loose and stranded seed implants Radiother Oncol 91 2009 202 206
38. P. Acher, S. Puttagunta, and K. Rhode An analysis of intraoperative versus post-operative dosimetry with CT, CT-MRI fusion and XMR for the evaluation of permanent prostate brachytherapy implants Radiother Oncol 96 2010 166 171
39. J. Yuen, M.J. Zelefsky, and J.J. Park Long-term outcome of MRSI-directed dose escalation for prostate brachytherapy Brachytherapy 8 2009 168
40. A.V. Taira, G.S. Merrick, and R.W. Galbreath Distant metastases following permanent interstitial brachytherapy for patients with clinically localized prostate cancer Int J Radiat Oncol Biol Phys 8 2011 8
41. J.E. Sylvester, P.D. Grimm, J. Wong, R.W. Galbreath, G. Merrick, and J.C. Blasko Fifteen-year biochemical relapse-free survival, cause-specific survival, and overall survival following I(125) prostate brachytherapy in clinically localized prostate cancer: Seattle experience Int J Radiat Oncol Biol Phys 81 2011 376 381
42. M.J. Zelefsky, D.A. Kuban, and L.B. Levy Multi-institutional analysis of long-term outcome for stages T1-T2 prostate cancer treated with permanent seed implantation Int J Radiat Oncol Biol Phys 67 2007 327 333 (Pubitemid 46108308)
43. J.J. Battermann, T.A. Boon, and M.A. Moerland Results of permanent prostate brachytherapy, 13 years of experience at a single institution Radiother Oncol 71 2004 23 28 (Pubitemid 38452898)
44. D. Ash, B. Al-Qaisieh, D. Bottomley, B. Carey, and J. Joseph The correlation between D90 and outcome for I-125 seed implant monotherapy for localised prostate cancer Radiother Oncol 79 2006 185 189 (Pubitemid 43884945)
45. F. Guedea, F. Aguilo, and A. Polo Early biochemical outcomes following permanent interstitial brachytherapy as monotherapy in 1050 patients with clinical T1-T2 prostate cancer Radiother Oncol 80 2006 57 61 (Pubitemid 44226432)
46. J.M. Cosset, T. Flam, and N. Thiounn Selecting patients for exclusive permanent implant prostate brachytherapy: the experience of the Paris Institut Curie/Cochin Hospital/Necker Hospital group on 809 patients Int J Radiat Oncol Biol Phys 71 2008 1042 1048
47. S.H. Aaltomaa, V.V. Kataja, T. Lahtinen, J.E. Palmgren, and T. Forsell Eight years experience of local prostate cancer treatment with permanent I(125) seed brachytherapy - morbidity and outcome results Radiother Oncol 91 2009 213 216
48. K.A. Hinnen, M.A. Moerland, and J.J. Battermann Loose seeds versus stranded seeds in I-125 prostate brachytherapy: differences in clinical outcome Radiother Oncol 96 2010 30 33
49. A.M. Henry, B. Al-Qaisieh, and K. Gould Outcomes following iodine-125 monotherapy for localized prostate cancer: the results of Leeds 10-year single-center brachytherapy experience Int J Radiat Oncol Biol Phys 76 2010 50 56
50. K.A. Hinnen, J.J. Battermann, and J.G. van Roermund Long-term biochemical and survival outcome of 921 patients treated with I-125 permanent prostate brachytherapy Int J Radiat Oncol Biol Phys 76 2010 1433 1438
51. M. Pinkawa, M.D. Piroth, and R. Holy Prostate-specific antigen kinetics following external-beam radiotherapy and temporary (Ir-192) or permanent (I-125) brachytherapy for prostate cancer Radiother Oncol 96 2010 25 29
52. E.M. Roeloffzen, M.V. Vulpen, J.J. Battermann, J.G. van Roermund, E.P. Saibishkumar, and E.M. Monninkhof Pretreatment nomogram to predict the risk of acute urinary retention after I-125 prostate brachytherapy Int J Radiat Oncol Biol Phys 30 2010 30
53. D. Bottomley, D. Ash, and B. Al-Qaisieh Side effects of permanent I125 prostate seed implants in 667 patients treated in Leeds Radiother Oncol 82 2007 46 49 (Pubitemid 46097133)
54. M.J. Steggerda, H.G. van der Poel, and L.M.F. Moonen An analysis of the relation between physical characteristics of prostate I-125 seed implants and lower urinary tract symptoms: bladder hotspot dose and prostate size are significant predictors Radiother Oncol 88 2008 108 114 (Pubitemid 351894940)
55. D. Vordermark, M. Noe, and K. Markert Prospective evaluation of quality of life after permanent prostate brachytherapy with I-125: importance of baseline symptoms and of prostate-V150 Radiother Oncol 91 2009 217 224
56. J.M. Crook, L. Potters, R.G. Stock, and M.J. Zelefsky Critical organ dosimetry in permanent seed prostate brachytherapy: defining the organs at risk Brachytherapy 4 2005 186 194 (Pubitemid 41338051)
57. G.J. Van der Wielen, J.P. Mulhall, and L. Incrocci Erectile dysfunction after radiotherapy for prostate cancer and radiation dose to the penile structures: a critical review Radiother Oncol 84 2007 107 113 (Pubitemid 47284535)
58. M. Pinkawa, B. Asadpour, and M.D. Piroth Health-related quality of life after permanent I-125 brachytherapy and conformal external beam radiotherapy for prostate cancer - a matched-pair comparison Radiother Oncol 91 2009 225 231
59. D.J. Farnell, P. Mandall, and C. Anandadas Development of a patient-reported questionnaire for collecting toxicity data following prostate brachytherapy Radiother Oncol 97 2010 136 142
60. S.J. Frank, V.E. Arterbery, and I.C. Hsu American College of Radiology Appropriateness Criteria permanent source brachytherapy for prostate cancer Brachytherapy 10 2011 357 362
61. Frank SJ, Levy LB, van Vulpen M, et al. Outcomes after prostate brachytherapy are even better than predicted. Cancer; doi:10.1002/cncr.26307.
62. Peinemann F, Grouven U, Bartel C, et al. Permanent interstitial low-dose-rate brachytherapy for patients with localised prostate cancer: a systematic review of randomised and nonrandomised controlled clinical trials. Eur Urol; doi:10.1016/j.eururo.2011.06.044.
63. F. Peinemann, U. Grouven, and L.G. Hemkens Low-dose rate brachytherapy for men with localized prostate cancer Cochrane Database Syst Rev 6 2011 CD008871
64. J.M. Crook, A. Gomez-Iturriaga, and K. Wallace Comparison of health-related quality of life 5 years after SPIRIT: Surgical Prostatectomy versus Interstitial Radiation Intervention Trial J Clin Oncol 29 2011 362 368
65. A.A. Martinez, J. Demanes, C. Vargas, L. Schour, M. Ghilezan, and G.S. Gustafson High-dose-rate prostate brachytherapy: an excellent accelerated-hypofractionated treatment for favorable prostate cancer Am J Clin Oncol 33 2010 481 488
66. L. Aström, D. Pedersen, C. Mercke, S. Holmang, and K.A. Johansson Long-term outcome of high dose rate brachytherapy in radiotherapy of localised prostate cancer Radiother Oncol 74 2005 157 161 (Pubitemid 40331872)
67. Y. Yoshioka, K. Konishi, and R.J. Oh High-dose-rate brachytherapy without external beam irradiation for locally advanced prostate cancer Radiother Oncol 80 2006 62 68 (Pubitemid 44226435)
68. Y. Yoshioka, K. Konishi, and I. Sumida Monotherapeutic high-dose-rate brachytherapy for prostate cancer: five-year results of an extreme hypofractionation regimen with 54 Gy in nine fractions Int J Radiat Oncol Biol Phys 80 2011 469 475
69. T. Martin, D. Baltas, and R. Kurek 3-D conformal HDR brachytherapy as monotherapy for localized prostate cancer. A pilot study Strahlenther Onkol 180 2004 225 232 (Pubitemid 38461547)
70. Barkati M, Williams SG, Foroudi F, et al. High-dose-rate brachytherapy as a monotherapy for favorable-risk prostate cancer: a phase II trial. Int J Radiat Oncol Biol Phys; doi:10.1016/j.ijrobp.2010.09.006.
71. Hoskin P, Rojas A, Lowe G, et al. High-dose-rate brachytherapy alone for localized prostate cancer in patients at moderate or high risk of biochemical recurrence. Int J Radiat Oncol Biol Phys, doi:10.1016/j.ijrobp.2011.04.031.
72. S.G. Williams, J.M. Taylor, and N. Liu Use of individual fraction size data from 3756 patients to directly determine the alpha/beta ratio of prostate cancer Int J Radiat Oncol Biol Phys 68 2007 24 33 (Pubitemid 46589844)
73. P. Nickers, J. Hermesse, J.M. Deneufbourg, S. Vanbelle, and E. Lartigau Which alpha/beta ratio and half-time of repair are useful for predicting outcomes in prostate cancer? Radiother Oncol 97 2010 462 466
74. C.B. Neviani, M.A. Miziara, and H. de Andrade Carvalho Results of high dose-rate brachytherapy boost before 2D or 3D external beam irradiation for prostate cancer Radiother Oncol 98 2011 169 174
75. A.A. Martinez, J. Gonzalez, and H. Ye Dose escalation improves cancer-related events at 10 years for intermediate- and high-risk prostate cancer patients treated with hypofractionated high-dose-rate boost and external beam radiotherapy Int J Radiat Oncol Biol Phys 79 2011 363 370
76. A.C. Pellizzon, J. Salvajoli, and P. Novaes The relationship between the biochemical control outcomes and the quality of planning of high-dose rate brachytherapy as a boost to external beam radiotherapy for locally and locally advanced prostate cancer using the RTOG-ASTRO Phoenix definition Int J Med Sci 5 2008 113 120 (Pubitemid 351880764)
77. B.R. Pieters, J.B. van de Kamer, and Y.R. van Herten Comparison of biologically equivalent dose-volume parameters for the treatment of prostate cancer with concomitant boost IMRT versus IMRT combined with brachytherapy Radiother Oncol 88 2008 46 52
78. R.M. Galalae, A. Martinez, and T. Mate Long-term outcome by risk factors using conformal high-dose-rate brachytherapy (HDR-BT) boost with or without neoadjuvant androgen suppression for localized prostate cancer Int J Radiat Oncol Biol Phys 58 2004 1048 1055 (Pubitemid 38314785)
79. G. Koukourakis, N. Kelekis, V. Armonis, and V. Kouloulias Brachytherapy for prostate cancer: a systematic review Adv Urol 327945 2009
80. Agoston P, Major T, Frohlich G, et al. Moderate dose escalation with single-fraction high-dose rate brachytherapy boost for clinically localized intermediate- and high-risk prostate cancer: 5-year outcome of the first 100 consecutively treated patients. Brachytherapy; doi:10.1016/j.brachy.2011.01.003.
81. G. Morton, A.D. Loblaw, and P. Cheung Is single fraction 15 Gy the preferred high dose-rate brachytherapy boost dose for prostate cancer? Radiother Oncol 100 2011 463 467
82. N.N. Stone, L. Potters, and B.J. Davis Multicenter analysis of effect of high biologic effective dose on biochemical failure and survival outcomes in patients with Gleason score 7-10 prostate cancer treated with permanent prostate brachytherapy Int J Radiat Oncol Biol Phys 73 2009 341 346
83. P. Nickers, B. Thissen, N. Jansen, and J.M. Deneufbourg 192Ir or 125I prostate brachytherapy as a boost to external beam radiotherapy in locally advanced prostatic cancer: a dosimetric point of view Radiother Oncol 78 2006 47 52 (Pubitemid 43131035)
84. N.P. Munro, B. Al-Qaisieh, and P. Bownes Outcomes from Gleason 7, intermediate risk, localized prostate cancer treated with Iodine-125 monotherapy over 10 years Radiother Oncol 96 2010 34 37
85. B.R. Pieters, E.D. Geijsen, and K. Koedooder Treatment results of PDR brachytherapy combined with external beam radiotherapy in 106 patients with intermediate- to high-risk prostate cancer Int J Radiat Oncol Biol Phys 79 2011 1037 1042
86. B.R. Pieters, D.Z. de Back, C.C. Koning, and A.H. Zwinderman Comparison of three radiotherapy modalities on biochemical control and overall survival for the treatment of prostate cancer: a systematic review Radiother Oncol 93 2009 168 173
87. I. Deutsch, M.J. Zelefsky, and Z. Zhang Comparison of PSA relapse-free survival in patients treated with ultra-high-dose IMRT versus combination HDR brachytherapy and IMRT Brachytherapy 9 2010 313 318
88. P.J. Hoskin, K. Motohashi, P. Bownes, L. Bryant, and P. Ostler High dose rate brachytherapy in combination with external beam radiotherapy in the radical treatment of prostate cancer: initial results of a randomised phase three trial Radiother Oncol 84 2007 114 120 (Pubitemid 47284526)
89. G.M. Duchesne, S.G. Williams, R. Das, and K.H. Tai Patterns of toxicity following high-dose-rate brachytherapy boost for prostate cancer: mature prospective phase I/II study results Radiother Oncol 84 2007 128 134 (Pubitemid 47284528)
90. L. Sullivan, S.G. Williams, K.H. Tai, F. Foroudi, L. Cleeve, and G.M. Duchesne Urethral stricture following high dose rate brachytherapy for prostate cancer Radiother Oncol 91 2009 232 236
91. P. Ghadjar, O. Matzinger, and B. Isaak Association of urethral toxicity with dose exposure in combined high-dose-rate brachytherapy and intensity-modulated radiation therapy in intermediate- and high-risk prostate cancer Radiother Oncol 91 2009 237 242
92. I.K. Kolkman-Deurloo, M.A. Roos, and S. Aluwini HDR monotherapy for prostate cancer: a simulation study to determine the effect of catheter displacement on target coverage and normal tissue irradiation Radiother Oncol 98 2011 192 197
93. T. Simnor, S. Li, and G. Lowe Justification for inter-fraction correction of catheter movement in fractionated high dose-rate brachytherapy treatment of prostate cancer Radiother Oncol 93 2009 253 258
94. P.J. Hoskin, P.J. Bownes, P. Ostler, K. Walker, and L. Bryant High dose rate afterloading brachytherapy for prostate cancer: catheter and gland movement between fractions Radiother Oncol 68 2003 285 288 (Pubitemid 38373429)
95. B.R. Pieters, J.N. van der Grient, L.E. Blank, K. Koedooder, M.C. Hulshof, and T.M. de Reijke Minimal displacement of novel self-anchoring catheters suitable for temporary prostate implants Radiother Oncol 80 2006 69 72 (Pubitemid 44226436)
96. Y. Seppenwoolde, I.-K. Kolkman-Deurloo, and D. Sipkema HDR prostate monotherapy - dosimetric effects of implant deformation due to posture change between TRUS- and CT-imaging Radiother Oncol 86 2008 114 119
97. R. Pötter Publications of brachytherapy articles: overview and current trends with focus on "Radiotherapy and Oncology" Radiother Oncol 99 2011 S74
98. C. Chargari, N. Magne, and I. Dumas Physics contributions and clinical outcome with 3D-MRI-based pulsed-dose-rate intracavitary brachytherapy in cervical cancer patients Int J Radiat Oncol Biol Phys 74 2009 185 193
99. C. Haie-Meder, C. Chargari, A. Rey, I. Dumas, P. Morice, and N. Magne MRI-based low dose-rate brachytherapy experience in locally advanced cervical cancer patients initially treated by concomitant chemoradiotherapy Radiother Oncol 96 2010 161 165
100. C. Haie-Meder, C. Chargari, A. Rey, I. Dumas, P. Morice, and N. Magne DVH parameters and outcome for patients with early-stage cervical cancer treated with preoperative MRI-based low dose rate brachytherapy followed by surgery Radiother Oncol 93 2009 316 321
101. J. Dimopoulos, S. Lang, and C. Kirisits Dose-effect relationship for local control of cervical cancer by magnetic resonance image guided brachytherapy Radiother Oncol 93 2009 311 315
102. R. Pötter, J. Dimopoulos, and P. Georg Clinical impact of MRI assisted dose-volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer Radiother Oncol 83 2007 148 155 (Pubitemid 46783926)
103. R. Pötter, P. Georg, and J.C. Dimopoulos Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer Radiother Oncol 100 2011 116 123
104. U. Mahantshetty, J. Swamidas, N. Khanna, R. Engineer, N.H. Merchant, and S. Shrivastava Magnetic resonance image-based dose-volume parameters and clinical outcome with high dose rate brachytherapy in cervical cancers - a validation of GYN GEC-ESTRO brachytherapy recommendations Clin Oncol (R Coll Radiol) 23 2011 376 377
105. Dimopoulos J, Petrow P, Tanderup K, et al. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (IV): basic principles and parameters for MR Imaging within the frame of image based adaptive cervix cancer brachytherapy. Radiother Oncol, submitted.
106. A.N. Viswanathan, J. Dimopoulos, C. Kirisits, D. Berger, and R. Pötter Computed tomography versus magnetic resonance imaging-based contouring in cervical cancer brachytherapy: results of a prospective trial and preliminary guidelines for standardized contours Int J Radiat Oncol Biol Phys 68 2007 491 498 (Pubitemid 46694166)
107. L.T. Tan, C.E. Coles, C. Hart, and E. Tait Clinical impact of computed tomography-based image-guided brachytherapy for cervix cancer using the tandem-ring applicator - the Addenbrooke's experience Clin Oncol (R Coll Radiol) 21 2009 175 182
108. S. Van Dyk, K. Narayan, R. Fisher, and D. Bernshaw Conformal brachytherapy planning for cervical cancer using transabdominal ultrasound Int J Radiat Oncol Biol Phys 75 2009 64 70
109. H.C. Kang, K.H. Shin, S.Y. Park, and J.Y. Kim 3D CT-based high-dose-rate brachytherapy for cervical cancer: clinical impact on late rectal bleeding and local control Radiother Oncol 97 2010 507 513
110. C. Charra-Brunaud, M. Levitchi, and M. Delannes Dosimetric and clinical results of a French prospective study of 3D brachytherapy for cervix carcinoma Radiother Oncol 99 2011
111. D.J. Ma, J.M. Zhu, and P.W. Grigsby Tumor volume discrepancies between FDG-PET and MRI for cervical cancer Radiother Oncol 98 2011 139 142
112. L.L. Lin, S. Mutic, and D.A. Low Adaptive brachytherapy treatment planning for cervical cancer using FDG-PET Int J Radiat Oncol Biol Phys 67 2007 91 96 (Pubitemid 44959479)
113. C. Haie-Meder, R. Mazeron, and N. Magne Clinical evidence on PET-CT for radiation therapy planning in cervix and endometrial cancers Radiother Oncol 96 2010 351 355
114. S. Haack, E.M. Pedersen, S.N. Jespersen, J.F. Kallehauge, J.C. Lindegaard, and K. Tanderup Apparent diffusion coefficients in GEC ESTRO target volumes for image guided adaptive brachytherapy of locally advanced cervical cancer Acta Oncol 49 2010 978 983
115. J.F. Kallehauge, K. Tanderup, and S. Haack Apparent Diffusion Coefficient (ADC) as a quantitative parameter in diffusion weighted MR imaging in gynecologic cancer: dependence on b-values used Acta Oncol 49 2010 1017 1022
116. M. Schuetz, M.P. Schmid, and R. Potter Evaluating repetitive 18F-fluoroazomycin-arabinoside (18FAZA) PET in the setting of MRI guided adaptive radiotherapy in cervical cancer Acta Oncol 49 2010 941 947
117. R. Wills, G. Lowe, D. Inchley, C. Anderson, V. Beenstock, and P. Hoskin Applicator reconstruction for HDR cervix treatment planning using images from 0.35 T open MR scanner Radiother Oncol 94 2010 346 352
118. K. Tanderup, T.P. Hellebust, and S. Lang Consequences of random and systematic reconstruction uncertainties in 3D image based brachytherapy in cervical cancer Radiother Oncol 89 2008 156 163
119. T.P. Hellebust, K. Tanderup, E.S. Bergstrand, B.H. Knutsen, J. Roislien, and D.R. Olsen Reconstruction of a ring applicator using CT imaging: impact of the reconstruction method and applicator orientation Phys Med Biol 52 2007 4893 4904 (Pubitemid 47232294)
120. D. Berger, J. Dimopoulos, R. Pötter, and C. Kirisits Direct reconstruction of the Vienna applicator on MR images Radiother Oncol 93 2009 347 351
121. A.A. De Leeuw, M.A. Moerland, C. Nomden, R.H. Tersteeg, J.M. Roesink, and I.M. Jurgenliemk-Schulz Applicator reconstruction and applicator shifts in 3D MR-based PDR brachytherapy of cervical cancer Radiother Oncol 93 2009 341 346
122. S. Haack, S.K. Nielsen, J.C. Lindegaard, J. Gelineck, and K. Tanderup Applicator reconstruction in MRI 3D image-based dose planning of brachytherapy for cervical cancer Radiother Oncol 91 2009 187 193
123. J. Perez-Calatayud, F. Kuipers, and F. Ballester Exclusive MRI-based tandem and colpostats reconstruction in gynaecological brachytherapy treatment planning Radiother Oncol 91 2009 181 186
124. T.P. Hellebust, C. Kirisits, and D. Berger Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group: considerations and pitfalls in commissioning and applicator reconstruction in 3D image-based treatment planning of cervix cancer brachytherapy Radiother Oncol 96 2010 153 160
125. S. Lang, A. Nulens, and E. Briot Intercomparison of treatment concepts for MR image assisted brachytherapy of cervical carcinoma based on GYN GEC-ESTRO recommendations Radiother Oncol 78 2006 185 193 (Pubitemid 43344179)
126. J. Dimopoulos, V. De Vos, and D. Berger Inter-observer comparison of target delineation for MRI-assisted cervical cancer brachytherapy: application of the GYN GEC-ESTRO recommendations Radiother Oncol 91 2009 166 172
127. P. Petric, J. Dimopoulos, C. Kirisits, D. Berger, R. Hudej, and R. Potter Inter- and intraobserver variation in HR-CTV contouring: intercomparison of transverse and paratransverse image orientation in 3D-MRI assisted cervix cancer brachytherapy Radiother Oncol 89 2008 164 171
128. K. Tanderup, R. Potter, J.C. Lindegaard, D. Berger, A. Wambersie, and C. Kirisits PTV margins should not be used to compensate for uncertainties in 3D image guided intracavitary brachytherapy Radiother Oncol 97 2010 495 500
129. C. Kirisits, R. Pötter, S. Lang, J. Dimopoulos, N. Wachter-Gerstner, and D. Georg Dose and volume parameters for MRI-based treatment planning in intracavitary brachytherapy for cervical cancer Int J Radiat Oncol Biol Phys 62 2005 901 911 (Pubitemid 40779785)
130. M. De Brabandere, A.G. Mousa, A. Nulens, A. Swinnen, and E. Van Limbergen Potential of dose optimisation in MRI-based PDR brachytherapy of cervix carcinoma Radiother Oncol 88 2008 217 226
131. J.C. Lindegaard, K. Tanderup, S.K. Nielsen, S. Haack, and J. Gelineck MRI-guided 3D optimization significantly improves DVH parameters of pulsed-dose-rate brachytherapy in locally advanced cervical cancer Int J Radiat Oncol Biol Phys 71 2008 756 764
132. I.M. Jürgenliemk-Schulz, S. Lang, and K. Tanderup Variation of treatment planning parameters (D90 HR-CTV, D2cc for OAR) for cervical cancer tandem ring brachytherapy in a multicentre setting: comparison of standard planning and 3D image guided optimisation based on a joint protocol for dose-volume constraints Radiother Oncol 94 2009 339 345
133. K. Tanderup, S.K. Nielsen, and G.B. Nyvang From point A to the sculpted pear: MR image guidance significantly improves tumour dose and sparing of organs at risk in brachytherapy of cervical cancer Radiother Oncol 94 2010 173 180
134. E. Chajon, I. Dumas, and M. Touleimat Inverse planning approach for 3-D MRI-based pulse-dose rate intracavitary brachytherapy in cervix cancer Int J Radiat Oncol Biol Phys 69 2007 955 961 (Pubitemid 47418421)
135. C.D. Kubicky, B.M. Yeh, and E. Lessard Inverse planning simulated annealing for magnetic resonance imaging-based intracavitary high-dose-rate brachytherapy for cervical cancer Brachytherapy 7 2008 242 247
136. D.H. Kim, A. Wang-Chesebro, and V. Weinberg High-dose rate brachytherapy using inverse planning simulated annealing for locoregionally advanced cervical cancer: a clinical report with 2-year follow-up Int J Radiat Oncol Biol Phys 75 2009 1329 1334
137. P. Trnkova, R. Pötter, and D. Baltas New inverse planning technology for image-guided cervical cancer brachytherapy: description and evaluation within a clinical frame Radiother Oncol 93 2009 331 340
138. S.V. Jamema, C. Kirisits, and U. Mahantshetty Comparison of DVH parameters and loading patterns of standard loading, manual and inverse optimization for intracavitary brachytherapy on a subset of tandem/ovoid cases Radiother Oncol 97 2010 501 506
139. I.M. Jürgenliemk-Schulz, S. Lang, and K. Tanderup Variation of treatment planning parameters (D90 HR-CTV, D2cc for OAR) for cervical cancer tandem ring brachytherapy in a multicentre setting: comparison of standard planning and 3D image guided optimisation based on a joint protocol for dose-volume constraints Radiother Oncol 94 2010 339 345
140. P. Trnkova, R. Potter, and D. Baltas New inverse planning technology for image-guided cervical cancer brachytherapy: description and evaluation within a clinical frame Radiother Oncol 93 2009 331 340
141. S. Lang, C. Kirisits, J. Dimopoulos, D. Georg, and R. Pötter Treatment planning for MRI assisted brachytherapy of gynecologic malignancies based on total dose constraints Int J Radiat Oncol Biol Phys 69 2007 619 627 (Pubitemid 47380110)
142. J.B. Van de Kamer, A.A. De Leeuw, M.A. Moerland, and I.M. Jurgenliemk-Schulz Determining DVH parameters for combined external beam and brachytherapy treatment: 3D biological dose adding for patients with cervical cancer Radiother Oncol 94 2010 248 253
143. A.A. De Leeuw, J.B. Van de Kamer, M.A. Moerland, M.E. Philippens, and I.M. Jurgenliemk-Schulz The effect of alternative biological modelling parameters (alpha/beta and half time of repair T(1/2)) on reported EQD2 values in the treatment of advanced cervical cancer Radiother Oncol 8 2011 8
144. C. Kirisits, S. Lang, J. Dimopoulos, K. Oechs, D. Georg, and R. Potter Uncertainties when using only one MRI-based treatment plan for subsequent high-dose-rate tandem and ring applications in brachytherapy of cervix cancer Radiother Oncol 81 2006 269 275 (Pubitemid 44869030)
145. U. Mahantshetty, S. Banerjee, S. Chopra, R. Engineer, and S.K. Shrivastava Clinical outcome of patients treated with template based high dose rate (HDR) interstitial brachytherapy boost in gynecological malignancies Radiother Oncol 99 2011
146. C. Kirisits, S. Lang, J. Dimopoulos, D. Berger, D. Georg, and R. Potter The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: design, application, treatment planning, and dosimetric results Int J Radiat Oncol Biol Phys 65 2006 624 630
147. J. Dimopoulos, C. Kirisits, and P. Petric The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: clinical feasibility and preliminary results Int J Radiat Oncol Biol Phys 66 2006 83 90 (Pubitemid 44175668)
148. I.M. Jürgenliemk-Schulz, R.J. Tersteeg, and J.M. Roesink MRI-guided treatment-planning optimisation in intracavitary or combined intracavitary/interstitial PDR brachytherapy using tandem ovoid applicators in locally advanced cervical cancer Radiother Oncol 93 2009 322 330
149. L. Fenkell, M. Assenholt, and S.K. Nielsen Parametrial boost using midline shielding results in an unpredictable dose to tumor and organs at risk in combined external beam radiotherapy and brachytherapy for locally advanced cervical cancer Int J Radiat Oncol Biol Phys 79 2011 1572 1579
150. M.P. Schmid, C. Kirisits, and N. Nesvacil Local recurrences in cervical cancer patients in the setting of image-guided brachytherapy: a comparison of spatial dose distribution within a matched pair analysis Radiother Oncol 100 2011 468 472
151. C. Kirisits, R. Potter, S. Lang, J. Dimopoulos, N. Wachter-Gerstner, and D. Georg Dose and volume parameters for MRI-based treatment planning in intracavitary brachytherapy for cervical cancer Int J Radiat Oncol Biol Phys 62 2005 901 911 (Pubitemid 40779785)
152. W.S. Koom, D.K. Sohn, and J.Y. Kim Computed tomography-based high-dose-rate intracavitary brachytherapy for uterine cervical cancer: preliminary demonstration of correlation between dose-volume parameters and rectal mucosal changes observed by flexible sigmoidoscopy Int J Radiat Oncol Biol Phys 68 2007 1446 1454 (Pubitemid 47176797)
153. P. Georg, R. Potter, and D. Georg Dose effect relationship for late side effects of the rectum and urinary bladder in magnetic resonance image-guided adaptive cervix cancer brachytherapy Int J Radiat Oncol Biol Phys 22 2011 22
154. P. Georg, C. Kirisits, and G. Goldner Correlation of dose-volume parameters, endoscopic and clinical rectal side effects in cervix cancer patients treated with definitive radiotherapy including MRI-based brachytherapy Radiother Oncol 91 2009 173 180
155. P. Georg, S. Lang, and J. Dimopoulos Dose-volume histogram parameters and late side effects in magnetic resonance image-guided adaptive cervical cancer brachytherapy Int J Radiat Oncol Biol Phys 79 2011 356 362
156. C.L. Holloway, M.L. Racine, R.A. Cormack, D.A. O'Farrell, and A.N. Viswanathan Sigmoid dose using 3D imaging in cervical-cancer brachytherapy Radiother Oncol 93 2009 307 310
157. S.P. Au, and P.W. Grigsby The irradiation tolerance dose of the proximal vagina Radiother Oncol 67 2003 77 85 (Pubitemid 36570443)
158. D. Berger, J. Dimopoulos, P. Georg, D. Georg, R. Potter, and C. Kirisits Uncertainties in assessment of the vaginal dose for intracavitary brachytherapy of cervical cancer using a tandem-ring applicator Int J Radiat Oncol Biol Phys 67 2007 1451 1459 (Pubitemid 46467164)
159. E.F. Fidarova, D. Berger, and S. Schussler Dose-volume parameter D2cc does not correlate with vaginal side effects in individual patients with cervical cancer treated within a defined treatment protocol with very high brachytherapy doses Radiother Oncol 97 2010 76 79
160. R.A. Nout, V.T. Smit, and H. Putter Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial Lancet 375 2010 816 823
161. L. Fokdal, K. Tanderup, and S.K. Nielsen Image and laparoscopic guided interstitial brachytherapy for locally advanced primary or recurrent gynaecological cancer using the adaptive GEC ESTRO target concept Radiother Oncol 100 2011 473 479
162. J. Dimopoulos, M.P. Schmid, E. Fidarova, D. Berger, C. Kirisits, and R. Potter Treatment of locally advanced vaginal cancer with radiochemotherapy and magnetic resonance image-guided adaptive brachytherapy: dose-volume parameters and first clinical results Int J Radiat Oncol Biol Phys 23 2011 23
163. B. Sorbe, B. Nordstrom, and J. Maenpaa Intravaginal brachytherapy in FIGO stage I low-risk endometrial cancer: a controlled randomized study Int J Gynecol Cancer 19 2009 873 878
164. C.L. Creutzberg, W.L. van Putten, and P.C. Koper Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma Lancet 355 2000 1404 1411 (Pubitemid 30215963)
165. H.M. Keys, J.A. Roberts, and V.L. Brunetto A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study Gynecol Oncol 92 2004 744 751 (Pubitemid 38251372)
166. C.L. Creutzberg, and R.A. Nout The role of radiotherapy in endometrial cancer: current evidence and trends Curr Oncol Rep 16 2011 16
167. R.A. Nout, L.V. van de Poll-Franse, and M.L. Lybeert Long-term outcome and quality of life of patients with endometrial carcinoma treated with or without pelvic radiotherapy in the post operative radiation therapy in endometrial carcinoma 1 (PORTEC-1) trial J Clin Oncol 29 2011 1692 1700
168. B. Sorbe, G. Horvath, H. Andersson, K. Boman, C. Lundgren, and B. Pettersson External pelvic and vaginal irradiation versus vaginal irradiation alone as postoperative therapy in medium-risk endometrial carcinoma - a prospective randomized study Int J Radiat Oncol Biol Phys 13 2011 13
169. S. Richardson, G. Palaniswaamy, and P.W. Grigsby Dosimetric effects of air pockets around high-dose rate brachytherapy vaginal cylinders Int J Radiat Oncol Biol Phys 78 2010 276 279
170. B.V. Offersen, M. Overgaard, N. Kroman, and J. Overgaard Accelerated partial breast irradiation as part of breast conserving therapy of early breast carcinoma: a systematic review Radiother Oncol 90 2009 1 13
171. S. Bernard, B. Reniers, P. Scalliet, and S. Vynckier Optimization of a breast implant in Brachytherapy PDR: validation with Monte Carlo simulation and measurements with TLDs and GafChromic films Radiother Oncol 76 2005 326 333 (Pubitemid 41394284)
172. P. Poortmans, H. Bartelink, and J.C. Horiot The influence of the boost technique on local control in breast conserving treatment in the EORTC 'boost versus no boost' randomised trial Radiother Oncol 72 2004 25 33 (Pubitemid 38952856)
173. P.M. Poortmans, L. Collette, and J.C. Horiot Impact of the boost dose of 10 Gy versus 26 Gy in patients with early stage breast cancer after a microscopically incomplete lumpectomy: 10-year results of the randomised EORTC boost trial Radiother Oncol 90 2009 80 85
174. A. Resch, R. Potter, and E. Van Limbergen Long-term results (10 years) of intensive breast conserving therapy including a high-dose and large-volume interstitial brachytherapy boost (LDR/HDR) for T1/T2 breast cancer Radiother Oncol 63 2002 47 58 (Pubitemid 34626754)
175. C. Polgar, J. Fodor, and T. Major Radiotherapy confined to the tumor bed following breast conserving surgery current status, controversies, and future projects Strahlenther Onkol 178 2002 597 606 (Pubitemid 35387834)
176. C. Polgar, J. Fodor, and Z. Orosz Electron and high-dose-rate brachytherapy boost in the conservative treatment of stage I-II breast cancer first results of the randomized Budapest boost trial Strahlenther Onkol 178 2002 615 623 (Pubitemid 35390398)
177. B.R. Pieters, A.E. Saarnak, M.J. Steggerda, and J.H. Borger A method to improve the dose distribution of interstitial breast implants using geometrically optimized stepping source techniques and dose normalization Radiother Oncol 58 2001 63 70 (Pubitemid 32124795)
178. B.R. Pieters, A.A. Hart, and N.S. Russell A comparison in cosmetic outcome between per-operative interstitial breast implants and delayed interstitial breast implants after external beam radiotherapy Radiother Oncol 67 2003 159 164 (Pubitemid 36695093)
179. P. Sminia, C.J. Schneider, G. van Tienhoven, K. Koedooder, L.E. Blank, and D. Gonzalez Gonzalez Office hours pulsed brachytherapy boost in breast cancer Radiother Oncol 59 2001 273 280 (Pubitemid 32429575)
180. C.A. Mangold, A. Rijnders, D. Georg, E. Van Limbergen, R. Potter, and D. Huyskens Quality control in interstitial brachytherapy of the breast using pulsed dose rate: treatment planning and dose delivery with an Ir-192 afterloading system Radiother Oncol 58 2001 43 51 (Pubitemid 32124793)
181. J. Hammer, D.H. Seewald, C. Track, J.P. Zoidl, and W. Labeck Breast cancer: primary treatment with external-beam radiation therapy and high-dose-rate iridium implantation Radiology 193 1994 573 577 (Pubitemid 24338354)
182. J. Hammer, J.J. Mazeron, and E. Van Limbergen Breast boost - why, how, when? Strahlenther Onkol 175 1999 478 483 (Pubitemid 29491371)
183. E. Touboul, Y. Belkacemi, and J.P. Lefranc Early breast cancer: influence of type of boost (electrons vs iridium-192 implant) on local control and cosmesis after conservative surgery and radiation therapy Radiother Oncol 34 1995 105 113
184. A. Fourquet, F. Campana, and V. Mosseri Iridium-192 versus cobalt-60 boost in 3-7 cm breast cancer treated by irradiation alone: final results of a randomized trial Radiother Oncol 34 1995 114 120
185. E. Van Limbergen, W. van den Bogaert, E. van der Schueren, and A. Rijnders Tumor excision and radiotherapy as primary treatment of breast cancer. Analysis of patient and treatment parameters and local control Radiother Oncol 8 1987 1 9 (Pubitemid 17003714)
186. E. Van Limbergen, A. Rijnders, E. van der Schueren, T. Lerut, and R. Christiaens Cosmetic evaluation of breast conserving treatment for mammary cancer. 2. A quantitative analysis of the influence of radiation dose, fractionation schedules and surgical treatment techniques on cosmetic results Radiother Oncol 16 1989 253 267 (Pubitemid 20015708)
187. E. Van Limbergen, E. van der Schueren, and K. van Tongelen Cosmetic evaluation of breast conserving treatment for mammary cancer. 1. Proposal of a quantitative scoring system Radiother Oncol 16 1989 159 167 (Pubitemid 20001694)
188. S. Leung, Y. Otmezguine, E. Calitchi, J.J. Mazeron, J.P. Le Bourgeois, and B. Pierquin Locoregional recurrences following radical external beam irradiation and interstitial implantation for operable breast cancer - a twenty three year experience Radiother Oncol 5 1986 1 10 (Pubitemid 16165813)
189. C. Polgar, E. Van Limbergen, and R. Potter Patient selection for accelerated partial-breast irradiation (APBI) after breast-conserving surgery: recommendations of the Groupe Europeen de Curietherapie-European Society for Therapeutic Radiology and Oncology (GEC-ESTRO) breast cancer working group based on clinical evidence (2009) Radiother Oncol 94 2010 264 273
190. M. Mannino, and J. Yarnold Accelerated partial breast irradiation trials: diversity in rationale and design Radiother Oncol 91 2009 16 22
191. C. Polgar, T. Major, and J. Fodor Accelerated partial-breast irradiation using high-dose-rate interstitial brachytherapy: 12-year update of a prospective clinical study Radiother Oncol 94 2010 274 279
192. V. Strnad, G. Hildebrandt, and R. Potter Accelerated partial breast irradiation: 5-year results of the German-Austrian multicenter phase II trial using interstitial multicatheter brachytherapy alone after breast-conserving surgery Int J Radiat Oncol Biol Phys 80 2011 17 24
193. O.J. Ott, G. Hildebrandt, and R. Pötter Accelerated partial breast irradiation with multi-catheter brachytherapy: local control, side effects and cosmetic outcome for 274 patients. Results of the German-Austrian multi-centre trial Radiother Oncol 82 2007 281 286 (Pubitemid 46341471)
194. D. Berger, D. Kauer-Dorner, W. Seitz, R. Potter, and C. Kirisits Concepts for critical organ dosimetry in three-dimensional image-based breast brachytherapy Brachytherapy 7 2008 320 326
195. J.B. Strauss, and A. Dickler Accelerated partial breast irradiation utilizing balloon brachytherapy techniques Radiother Oncol 91 2009 157 165
196. E. Van Limbergen Accelerated partial breast irradiation with intracavitary balloon brachytherapy may be not as simple as it was supposed to be Radiother Oncol 91 2009 147 149
197. Y. Belkacemi, M.P. Chauvet, and S. Giard Partial breast irradiation as sole therapy for low risk breast carcinoma: early toxicity, cosmesis and quality of life results of a MammoSite brachytherapy phase II study Radiother Oncol 90 2009 23 29
198. D.J. Scanderbeg, C. Yashar, R. Rice, and T. Pawlicki Clinical implementation of a new HDR brachytherapy device for partial breast irradiation Radiother Oncol 90 2009 36 42
199. P. Niehoff, C. Polgar, and H. Ostertag Clinical experience with the MammoSite radiation therapy system for brachytherapy of breast cancer: results from an international phase II trial Radiother Oncol 79 2006 316 320 (Pubitemid 44109912)
200. T. Major, P. Niehoff, G. Kovacs, J. Fodor, and C. Polgar Dosimetric comparisons between high dose rate interstitial and MammoSite balloon brachytherapy for breast cancer Radiother Oncol 79 2006 321 328 (Pubitemid 44109906)
201. C. Aristei, R. Tarducci, and I. Palumbo Computed tomography for excision cavity localization and 3D-treatment planning in partial breast irradiation with high-dose-rate interstitial brachytherapy Radiother Oncol 90 2009 43 47
202. A.M. Kirby, C.E. Coles, and J.R. Yarnold Target volume definition for external beam partial breast radiotherapy: clinical, pathological and technical studies informing current approaches Radiother Oncol 94 2010 255 263
203. D.A. DeBiose, E.M. Horwitz, and A.A. Martinez The use of ultrasonography in the localization of the lumpectomy cavity for interstitial brachytherapy of the breast Int J Radiat Oncol Biol Phys 38 1997 755 759 (Pubitemid 27310545)
204. S. Tatli, P.R. Morrison, K. Tuncali, and S.G. Silverman Interventional MRI for oncologic applications Tech Vasc Interv Radiol 10 2007 159 170 (Pubitemid 350216515)
205. E.C. Whipp, and M. Halliwell Magnetic resonance imaging appearances in the postoperative breast: the clinical target volume-tumor and its relationship to the chest wall Int J Radiat Oncol Biol Phys 72 2008 49 57
206. M. Jolicoeur, M.L. Racine, and I. Trop Localization of the surgical bed using supine magnetic resonance and computed tomography scan fusion for planification of breast interstitial brachytherapy Radiother Oncol 100 2011 480 484
207. T. Major, C. Polgar, J. Fodor, A. Somogyi, and G. Nemeth Conformality and homogeneity of dose distributions in interstitial implants at idealized target volumes: a comparison between the Paris and dose-point optimized systems Radiother Oncol 62 2002 103 111 (Pubitemid 34121955)
208. T. Major, G. Frohlich, K. Lovey, J. Fodor, and C. Polgar Dosimetric experience with accelerated partial breast irradiation using image-guided interstitial brachytherapy Radiother Oncol 90 2009 48 55
209. P. Georg, D. Georg, and E. Van Limbergen The use of the source-skin distance measuring bridge indeed reduces skin teleangiectasia after interstitial boost in breast conserving therapy Radiother Oncol 74 2005 323 330 (Pubitemid 40349143)
210. E. Van Limbergen, E. Briot, and M. Drijkoningen The source-skin distance measuring bridge: a method to avoid radiation teleangiectasia in the skin after interstitial therapy for breast cancer Int J Radiat Oncol Biol Phys 18 1990 1239 1244 (Pubitemid 20182361)
211. T. Major, C. Polgar, K. Lovey, and G. Frohlich Dosimetric characteristics of accelerated partial breast irradiation with CT image-based multicatheter interstitial brachytherapy: a single institution's experience Brachytherapy 24 2011 24
212. S. Lettmaier, S. Kreppner, and M. Lotter Radiation exposure of the heart, lung, skin by radiation therapy for breast cancer: a dosimetric comparison between partial breast irradiation using multicatheter brachytherapy, whole breast teletherapy Radiother Oncol 28 2010 28
213. A.J. Stewart, D.A. O'Farrell, and R.A. Cormack Dose-volume histogram analysis of normal structures associated with accelerated partial breast irradiation delivered by high dose rate brachytherapy, comparison with whole breast external beam radiotherapy fields Radiat Oncol 3 2008 39
214. B. Johansson, E. Persson, G. Westman, and J. Persliden Phantom study of radiation doses outside the target volume brachytherapy versus external radiotherapy of early breast cancer Radiother Oncol 69 2003 107 112 (Pubitemid 37346194)
215. B. Guix, J.A. Lejarcegui, and J.I. Tello Exeresis and brachytherapy as salvage treatment for local recurrence after conservative treatment for breast cancer: results of a ten-year pilot study Int J Radiat Oncol Biol Phys 78 2010 804 810
216. J.M. Hannoun-Levi, J. Castelli, and A. Plesu Second conservative treatment for ipsilateral breast cancer recurrence using high-dose rate interstitial brachytherapy: preliminary clinical results and evaluation of patient satisfaction Brachytherapy 10 2011 171 177
217. A. Resch, C. Fellner, and U. Mock Locally recurrent breast cancer: pulse dose rate brachytherapy for repeat irradiation following lumpectomy - a second chance to preserve the breast Radiology 225 2002 713 718 (Pubitemid 35387106)
218. Kauer-Dorner D, Pötter R, Resch A, et al. Partial breast irradiation for locally recurrent breast cancer within a second breast conserving treatment: alternative to mastectomy? Results from a prospective trial. Radiother Oncol; doi:10.1016/j.radonc.2011.07.020.
219. M. Aumont-le Guilcher, B. Prevost, and M.P. Sunyach High-dose-rate brachytherapy for non-small-cell lung carcinoma: a retrospective study of 226 patients Int J Radiat Oncol Biol Phys 79 2011 1112 1116
220. A. Colonias, J. Betler, and M. Trombetta Mature follow-up for high-risk stage I non-small-cell lung carcinoma treated with sublobar resection and intraoperative iodine-125 brachytherapy Int J Radiat Oncol Biol Phys 79 2011 105 109
221. J. Skowronek, M. Kubaszewska, M. Kanikowski, A. Chichel, and W. Mlynarczyk HDR endobronchial brachytherapy (HDRBT) in the management of advanced lung cancer - comparison of two different dose schedules Radiother Oncol 93 2009 436 440
222. S. Kumar, K. Dimri, R. Khurana, N. Rastogi, K.J. Das, and P. Lal A randomised trial of radiotherapy compared with cisplatin chemo-radiotherapy in patients with unresectable squamous cell cancer of the esophagus Radiother Oncol 83 2007 139 147 (Pubitemid 46776919)
223. Y. Murakami, Y. Nagata, and I. Nishibuchi Long-term outcomes of intraluminal brachytherapy in combination with external beam radiotherapy for superficial esophageal cancer Int J Clin Oncol 12 2011 12
224. E. Rosenblatt, G. Jones, and R.K. Sur Adding external beam to intra-luminal brachytherapy improves palliation in obstructive squamous cell oesophageal cancer: a prospective multi-centre randomized trial of the International Atomic Energy Agency Radiother Oncol 97 2010 488 494
225. C.T. Muijs, J.C. Beukema, V.E. Mul, J.T. Plukker, N.M. Sijtsema, and J.A. Langendijk External beam radiotherapy combined with intraluminal brachytherapy in esophageal carcinoma Radiother Oncol 2011 10.1016/j.radonc.2011.07.021
226. K.M. Verschueren, C.L. Creutzberg, and N.E. Schalij-Delfos Long-term outcomes of eye-conserving treatment with Ruthenium(106) brachytherapy for choroidal melanoma Radiother Oncol 95 2010 332 338
227. C.A. Marijnen External beam radiotherapy and high dose rate brachytherapy for medically unfit and elderly patients Clin Oncol (R Coll Radiol) 19 2007 706 710 (Pubitemid 47471503)
228. E. Van Limbergen, and P. Trepuraneni Is this the swan song of endovascular brachytherapy? Radiother Oncol 82 2007 1 4 (Pubitemid 46127473)
229. M. Guibert, I. David, and S. Vergez Brachytherapy in lip carcinoma: long-term results Int J Radiat Oncol Biol Phys 14 2010 14
230. R. Martinez-Monge, M. Pagola Divasson, and M. Cambeiro Determinants of complications, outcome in high-risk squamous cell head-and-neck cancer treated with Perioperative High-Dose Rate Brachytherapy (PHDRB) Int J Radiat Oncol Biol Phys 26 2011 26
231. N. Tselis, M. Ratka, and H.G. Vogt Hypofractionated accelerated CT-guided interstitial (1)(2)Ir-HDR-Brachytherapy as re-irradiation in inoperable recurrent cervical lymphadenopathy from head and neck cancer Radiother Oncol 98 2011 57 62
232. E.M. Vasquez Osorio, M.S. Hoogeman, and D.N. Teguh Three-dimensional dose addition of external beam radiotherapy and brachytherapy for oropharyngeal patients using nonrigid registration Int J Radiat Oncol Biol Phys 80 2011 1268 1277
233. D.N. Teguh, P.C. Levendag, I.K. Kolkman-Deurloo, P. van Rooij, and P.I. Schmitz Quality of life of oropharyngeal cancer patients treated with brachytherapy Curr Oncol Rep 11 2009 143 150
234. L.A. DeWerd, G.S. Ibbott, and A.S. Meigooni A dosimetric uncertainty analysis for photon-emitting brachytherapy sources: report of AAPM Task Group No. 138 and GEC-ESTRO Med Phys 38 2011 782 801
235. T. Schneider, and H.J. Selbach Realization of the absorbed dose to water for I-125 interstitial brachytherapy sources Radiother Oncol 100 2011 442 445
236. M.J. Rivard, B.M. Coursey, and L.A. DeWerd Update of AAPM Task Group No. 43 Report: a revised AAPM protocol for brachytherapy dose calculations Med Phys 31 2004 633 674 (Pubitemid 38381028)
237. G. Landry, B. Reniers, and P. Granton Extracting atomic numbers and electron densities from a dual source energy CT scanner: Experiments and a simulation model Radiother Oncol 100 2011 375 379
238. G. Kertzscher, C.E. Andersen, J.C. Lindegaard, S.K. Nielsen, and K. Tanderup Online detection of imposed brachytherapy errors in a phantom using fiber-coupled luminescence dosimetry Radiother Oncol 100 2011 456 462
239. J. Overgaard Advancing radiation oncology through scientific publication - 100 volumes of Radiother Oncol Radiother Oncol 100 2011 1 6
240. Howick J, Chalmers I, Glasziou P, et al. The 2011 Oxford CEBM levels of evidence: Oxford centre for evidence-based medicine; 2011. .